Aortic valve replacement is a surgical procedure performed to replace a diseased or damaged aortic valve in the heart, and it is usually operated through traditional open-heart surgery, which involves incising the chest or using minimally invasive (MI) methods that require smaller incisions in the chest or a catheter incorporated in the leg. According to MarketStack, the Global Aortic Valve Replacement Market is expected to grow considerably during the forecasted period. Factors such as the increasing prevalence of various valvular diseases such as aortic stenosis & aortic regurgitation and technological advancement are expected to drive the Aortic Valve Replacement Market in the forecasted period. Further, increasing demand for minimal-invasive procedures such as transcatheter aortic valve replacement (TAVR) is expected to drive the Aortic Valve Replacement Market in the forecasted period. Furthermore, the rise in the geriatric population due to aged individuals being more susceptible to aortic stenosis is expected to drive the Aortic Valve Replacement Market in the forecasted period. However, stringent government regulations for approval of transcatheter aortic valve and the risk associated with the procedure hinder the market's growth. Certain products have failed the tests due to incompetent results after clinical trials.

The aortic valve replacement market is the growing number of valvular diseases like aortic stenosis and aortic regurgitation, as well as technological advances in the heart valve market. Aortic stenosis is the most common disease of a valve that affects older people. Aortic valve replacement devices treat aortic stenosis, in which the aortic valve narrows blood flow from the heart to the rest of the body. These devices are meant to replace a damaged or diseased valve, thus enhancing blood flow and decreasing the chance of complications. Aortic stenosis (AS) is a condition wherein the aortic valve becomes narrow, thus reducing blood flow from the heart to the rest of the body. Valvular diseases refer to disorders that affect heart valves, which could lead to problems with blood flow through the heart. AS and valvular diseases are more common in older adults. Therefore, the increase in geriatric population is leading to a rise in number of people with these conditions. The increase in prevalence of AS and valvular diseases drives the demand for AVR devices, as these conditions could lead to severe complications, including heart failure, stroke, and death. Early diagnosis and treatment are crucial to prevent the progression of these conditions and reduce the risk of complications. Therefore, the surge in awareness about the importance of early diagnosis and treatment of AS and valvular diseases drives the aortic valve replacement devices market in the forecasted period.

North America is estimated to contribute to the growth of the global market during the forecast period. Some of the main factors that are significantly contributing to the development of the transcatheter aortic valve replacement (TAVR) market in North America include the high prevalence of heart-related disorders such as heart valve diseases, stenosis, and atresia and the increasing adoption of suture-less valves, tissue valves, and MI procedures and rapid growth in the older adult population. MIS procedures have improved patient outcomes and proven to be as effective as traditional open-heart surgery in several cases. This has made MIS a more viable option for patients and healthcare providers, leading to increased adoption. Advances in surgical techniques and instrumentation have made MIS procedures safer and more efficient. Ongoing development of new and innovative MIS techniques and devices is expected to propel aortic valve replacement devices market expansion. Hospitals are the primary healthcare settings for patients with aortic stenosis, as these procedures require specialized facilities and equipment. They are equipped with the latest medical technology and have highly trained medical staff, making them the ideal setting for aortic valve replacement procedures. Hospitals provide various medical services, including diagnostic testing, preoperative evaluations, and postoperative care. This makes them a convenient and accessible option for patients who need an aortic valve replacement, as all the necessary services are available in one location. The number of hospitals offering aortic valve replacement procedures has increased in the past few years. This has led to greater competition among hospitals, thus resulting in improved patient outcomes and lower costs. Transcatheter aortic valves are widely used because more people want minimal invasive surgeries. More research and development are being done on Transcatheter valves, and more people worldwide are learning about TAVR. Even though sutureless valves are not widely used, they offer a significant opportunity for growth because they have many benefits. Sutureless valves show good hemodynamic and post-surgery results and lower mortality. Only three valves without sutures have been put on the market are Enable 3F., the Perceval, and the Edwards Intuity Valve System. But there are several sutureless valves in the works that could help the field of sutureless valves grow even more. Tissue valves and mechanical valves make up the rest of the valves.

The market key players are Medtronic plc, Abbott Laboratories, Inc., Boston Scientific Corp., Meril Life Sciences Pvt. Ltd., Inc., and Edwards Lifesciences Corp.

In January 2023, Abbott received FDA approval for the Navitor transcatheter aortic valve implantation (TAVI) system to treat people with severe aortic stenosis at high risk of open-heart surgery. Navitor is the latest addition to the company's extensive transcatheter structural heart portfolio, which offers physicians and patients less invasive treatment options for a range of severe heart diseases.

The global Aortic Valve Replacement Market report provides deep insight into the Industrial Market's current and future state across various regions. The study comprehensively analyses the Aortic Valve Replacement market by segmenting it based on the By Valve Type (Tissue/Biological, Mechanical), Suture Type (Sutured, Sutureless), Procedure (Open Surgery, Minimally Invasive Surgery), End User (Hospitals, Ambulatory Surgery Centers), and Geography (Asia-Pacific, North America, Europe, South America, and Middle-East and Africa). The report examines the market drivers and restraints and the impact of COVID-19 on the market growth in detail. The study covers emerging market trends, developments, opportunities, and challenges in the industry. This report also covers extensively researched competitive landscape sections with prominent companies and profiles, including their market shares and projects.